Skip to content
AnalystLens
Back to EXELIncome Statement

Exelixis Gross Profit 2011-2027 | EXEL

Annual FY2011–FY2026 · quarterly through Q3 FY2027

Latest annual · FY2026

$2.24B

+6.9%YoY vs FY2025Source: 10-KFY2026

From $289.6M in FY2011 to $2.24B in FY2026: 7.7× in 15 years.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY27$591M+10.2%$608M+10.8%$632M+9.2%Not reported
FY26$536M+32.8%$549M−11.4%$579M+10.9%$572M+4.6%
FY25$404M$620M$522M$547M
FY23$394M+15.1%$452M+11.4%$453M+14.3%$613M+0.5%
FY22$343M+33.4%$406M+9.6%$396M+25.2%$609M
Share21%25%25%29%

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date. Share: its typical part of the fiscal year.

Key Statistics

Trend DirectionGrowing
CAGR

+19.1%

FY2020
$934.7M
FY2026
$2.24B

5 years selected · on the chart

Gross Profit History

Year-over-year comparison from 10-K annual reports

  1. $2.24B
YoY changeLargest recent move+89.2%in FY18Latest +6.9%

1 older move runs past ±150% (largest +1214.5%); point at, tap or drag across the bars to read one.

Gross Profit, period by period

PeriodValueChangeSource
FY2026$2.24B+6.9%10-K
FY2025$2.09B+19.0%10-K
FY2023$1.76B+13.2%10-K
FY2022$1.55B+12.4%10-K
FY2021$1.38B+47.9%10-K
FY2020$934.7M+13.0%10-K
FY2018$827.5M+89.2%10-K
FY2017$437.4M+1214.5%10-K
FY2016$33.3M0.0%flat10-K
FY2015$33.3M+44.3%10-K
FY2014$23.1M−23.7%10-K
FY2013$30.2M−36.3%10-K
FY2012$47.5M−83.6%10-K
FY2011$289.6M—10-K

What is gross profit?

Gross profit can be defined as revenue minus the cost of goods sold, representing the profit a company makes before deducting operating expenses.

What is Exelixis's current gross profit?

Exelixis (EXEL) annual gross profit for 2026 was $2.24B, a 6.88% increase from 2025. Exelixis gross profit for the quarter ending October 2, 2026 was $632.5M.

What was Exelixis's gross profit in 2025?

Exelixis annual gross profit for 2025 was $2.09B, a 19.05% increase from 2023.

What was Exelixis's gross profit in 2023?

Exelixis annual gross profit for 2023 was $1.76B, a 13.17% increase from 2022.

What is Exelixis's 5-year gross profit CAGR?

Exelixis gross profit grew at a compound annual growth rate (CAGR) of 10.10% from FY2021 to FY2026, going from $1.38B to $2.24B over 5 years.

Company
Exelixis
Ticker
EXEL
Sector
Healthcare
Industry
Biological Products, (No Diagnostic Substances)